Genting Berhad
Genting Berhad is a Malaysia-based investment holding company engaged in various sectors, including leisure and hospitality, oil palm plantations, power generation, oil and gas, property development, and life sciences. The company's Leisure & Hospitality segment encompasses gaming, hotels, food and beverages, theme parks, retail, and travel services, as well as the development and operation of integrated resorts. In the plantation sector, Genting Berhad focuses on oil palm cultivation and related milling activities. The power segment is responsible for generating and supplying electricity. Additionally, the company explores for, develops, and produces oil and gas, while its property segment involves property development and investment. Beyond these core areas, Genting Berhad manufactures biodiesel, provides project management services, and engages in technologies related to genetic analysis and Alzheimer’s research. Established in 1965 and headquartered in Kuala Lumpur, the company aims to enhance shareholder value and sustain long-term growth across its diverse business ventures.
Top Stages
https://crunchbase.com/organization/***
https://linkedin.com/company/***
6 past transactions
Cortechs.ai
Series C in 2024
Cortechs.ai is a developer of brain image analysis software that enhances clinical insight through quantitative imaging. The company's innovative solutions are utilized by neurologists and radiologists in numerous clinics and research centers globally. Its software provides a practical and cost-effective approach to quantifying brain structures, aiding medical professionals in the evaluation of various neurological conditions, including Alzheimer's disease, multiple sclerosis, epilepsy, and traumatic brain injury. Through its advanced imaging technology, Cortechs.ai aims to improve diagnostic accuracy and treatment outcomes in the field of neurology.
Sightline Payments
Private Equity Round in 2021
Sightline Payments specializes in digital payment solutions for the sports betting and casino gaming market. Its flagship product, Play+, enables cashless transactions across various gaming platforms, including online, mobile, slots, table games, and sports betting. The company's platform integrates multiple funding sources and idle cash management systems, enhancing efficiency and financial management for clients.
Sightline Payments
Private Equity Round in 2021
Sightline Payments specializes in digital payment solutions for the sports betting and casino gaming market. Its flagship product, Play+, enables cashless transactions across various gaming platforms, including online, mobile, slots, table games, and sports betting. The company's platform integrates multiple funding sources and idle cash management systems, enhancing efficiency and financial management for clients.
Nova Satra Dx
Seed Round in 2017
Nova Satra Dx is a molecular diagnostics company based in Singapore that focuses on the research, development, and commercialization of innovative blood-based diagnostic tests for cancer. Utilizing clinically validated technology from the University of Oxford, the company's tests leverage Asian-specific epigenetic biomarkers to provide rapid and accurate detection of various cancers, including breast, colon, prostate, stomach, and lung cancers. By identifying changes in gene expression linked to cancer, Nova Satra Dx aims to enhance early diagnosis and improve patient outcomes. Through its advanced diagnostic platform, the company seeks to empower both patients and healthcare providers in the fight against cancer.
DNAe
Series A in 2014
DNAe Ltd specializes in developing innovative diagnostic solutions for serious blood infections through the use of electronic microchip technology. The company focuses on creating a suite of products that facilitate faster, simpler, and more cost-effective DNA analysis, thereby enhancing the speed and accuracy of diagnosing critical health conditions. By leveraging advanced technology, DNAe aims to improve patient outcomes and streamline the diagnostic process in clinical settings.
Applied Proteomics
Series C in 2013
Applied Proteomics, Inc., founded in 2006 and headquartered in San Diego, California, specializes in developing noninvasive and blood-based tests for monitoring and early detection of disease. The company focuses on protein biomarkers, offering a proteomics platform that enables the discovery and application of these biomarkers in diagnostics and personalized medicine to enhance healthcare outcomes. One of their key products is the SimpliPro Colon test, which provides diagnostic solutions based on protein interactions within the body.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.